433
Views
11
CrossRef citations to date
0
Altmetric
Research Article

The applicability of four clinical methods to evaluate arm and hand function in all stages of spinal muscular atrophy type II

&
Pages 2120-2126 | Received 01 Feb 2013, Accepted 04 Feb 2014, Published online: 03 Mar 2014

References

  • Munsat TL, Davies KE. International SMA Consortium meeting report. Neuromuscul Disord 1992;2:423–8
  • Dubowitz V. Chaos in the classification of SMA: a possible resolution. Neuromuscul Disord 1995;5:3–5
  • Carter GT, Abresch RT, Fowler WM, et al. Profiles of neuromuscular diseases: spinal muscular atrophy. Am J Phys Med Rehabil 1995;74:150–9
  • Merlini L, Bertini E, Minetti C, et al. Motor function-muscle strength relationship in spinal muscular atrophy. Muscle Nerve 2004;29:548–52
  • Werlauff U, Steffensen BT, Bertelsen S, et al. Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients. Neuromuscul Disord 2010;1:34–43
  • Zerres K, Rudnik-Schöneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestion for a modification of existing classifications. Arch Neurol 1995;52:518–23
  • Werlauff U, Vissing J, Steffensen BF. Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study. Neuromuscul Disord 2012;12:1069–74
  • Jeppesen J, Madsen A, Marquardt J, Rahbek J. Living and ageing with spinal muscular atrophy type 2: observations among an unexplored patient population. Dev Neurorehabil 2010;13:10–18
  • WHO. International Classification of Functioning, Disability and Health. Final Draft. Geneva: World Health Organization; 2001
  • Montes J, Gordon AM, Pandya S, et al. Clinical outcome measures in spinal muscular atrophy. J Child Neurol 2009;24:968–78
  • Brooke MH, Griggs RC, Mendell JR, et al. Clinical trial in Duchenne dystrophy. The design of the protocol. Muscle Nerve 1981;4:186–97
  • Florence JM, Pandya S, King W, et al. Clinical Trials in Duchenne Dystrophy. Standardization and reliability of evaluation procedures. Phys Ther 1984;64:41–5
  • Steffensen BF, Hyde SA, Lyager S, Mattson E. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy. Physiother Res Int 2001;6:119–23
  • Bérard C, Payan C, Hodgkinson I, et al. A motor function measure scale for neuromuscular diseases. Construction and validation study. Neuromusc Disord 2005;15:463–70
  • Lue YJ, Su CY, Yang RC, et al. Development and validation of a muscular dystrophy-specific functional rating scale. Clin Rehabil 2006;20:804–17
  • Mazzone E, Bianco F, Martinelli D, et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromusc Disord 2011;21:406–12
  • Servais L, Deconinck N, Moraux A, et al. Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients. Neuromuscul Disord 2013;23:139–48
  • Medical Research Council. Aids to the investigation of peripheral nerve injuries. London: Her Majesty’s Stationary Office; 1976
  • Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 1982;5:291–301
  • Merlini L, Mazzone ES, Solari A, Morandi L. Reliability of hand-held dynamometry in spinal muscular atrophy. Muscle Nerve 2002;26:64–70
  • Mahony K, Hunt A, Daley D, et al. Inter-tester reliability and precision of manual muscle testing and hand-held dynamometry in lower limb muscles of children with spina bifida. Phys Occup Ther Pediatr 2009;29:44–59
  • Febrer A, Rodriguez N, Alias L, Tizzano E. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy. J Rehabil Med 2010;42:228–31
  • Steffensen BF, Mayhew A, Aloysius A, et al. Egen Klassifikation (EK) revisited in spinal muscular atrophy. Neuromuscul Disord 2008;18:740–1
  • Escolar DM, Henricson EK, Mayhew J, et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 2001;24:787–93
  • Iannaccone ST, Russman BS, Browne RH, et al. Prospective analysis of strength in spinal muscular atrophy. J Child Neurol 2000;15:97–101
  • Miller RG, Moore DH, Dronsky V, et al. SMA Study Group. A placebo-controlled trial of gabapentin in spinal muscular atrophy. J Neurol Sci 2001;191:127–31
  • Bartels B, Pangalila RF, Bergen MP, et al. Upper limb function in adults with Duchenne muscular dystrophy. J Rehabil Med 2011;43:770–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.